GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Arena Pharmaceuticals, Inc. (ARNA) [hlAlert]

Rating:
Outperform
ARNA
down 69.95 %

Arena Pharmaceuticals, Inc. (ARNA) upgraded to Outperform by Leerink Swann

Posted on: Wednesday,  Feb 6, 2013  8:25 AM ET by Leerink Swann

Leerink Swann rated Outperform Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) on 02/06/2013, when the stock price was $8.82.
Since then, Arena Pharmaceuticals, Inc. has lost 69.95% as of 10/08/2015's recent price of $2.65.
If you would have followed this Leerink Swann 's recommendation on ARNA, you would have lost 69.95% of your investment in 974 days.

Arena Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory, and metabolic diseases. Arena's most advanced product candidate, lorcaserin, is being investigated in a Phase three clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/6/2013 8:25 AM Buy
None
8.82
as of 12/13/2013
1 Week down  -6.55 %
1 Month up  6.92 %
3 Months down  -8.25 %
1 YTD down  -36.96 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/21/2009 8:25 AM Hold
None
4.97 6.00
8/25/2008 9:25 AM Buy
None
6.29

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy